Molecule

S2516 

Research Area: Neurological Disease
Biological Activity:
Xylazine HCl is α2 class of adrenergic receptor agonist. As with other α2 agonists, adverse effects include bradycardia, conduction disturbances, and myocardial depression. It is a clonidine analoque. It acts on presynaptic and postsynaptic receptors of the central and peripheral nervous systems as an a 2-adrenergic agonist. It is used primarily for sedation, anesthesia, analgesia and muscle relaxation but it has numerous other pharmacological effects. Most of these effects consist of bradycardia and hypotension. It inhibits the effects of postganglionic nerve stimulation. [1]References on Xylazine HCl[1] http://en.wikipedia.org/wiki/Xylazine, ,

02158306 

Free Base

X1126 

Biochem/physiol Actions
α2-adrenoceptor agonist, sedative, muscle relaxant.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. X1126.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

CHEBI:92386 

A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.